intracerebral%20hemorrhage
INTRACEREBRAL HEMORRHAGE
Intracerebral hemorrhage is the sudden burst of blood into the brain tissue itself.
It causes sudden onset of focal neurological deficit.
The focal neurologic findings are related to the anatomic location, size and speed of development of intracerebral hemorrhage.
Neurological deficit usually progresses over a minute to an hour.
Rapid recognition and diagnosis of intracerebral hemorrhage are essential because of its frequently rapid progression.

History

  • Assess presenting symptoms and associated activities at onset
  • Determine time of stroke onset and age

Physical Examination

  • Vital signs
  • General examination of the head, heart, lungs, abdomen and extremities
  • Brief but through neurologic exam [eg National Institute of Health Stroke Scale (NIHSS), Glasgow Coma Scale (GCS)]

Laboratory Tests

  • Complete blood count (CBC), international normalized ratio (INR), prothrombin time (PT), activated partial thromboplastin time (aPTT), electrolytes, blood urea nitrogen (BUN), creatinine, glucose
  • Urinalysis
  • Echocardiography (ECG), chest X-ray
  • Toxicology screen to rule out illicit drug use (eg cocaine, methamphetamine)

Imaging

  • The earlier time from onset of neurological symptoms to initial neuroimage, the more likely succeeding neuroimages will show hematoma expansion
  • Hematoma expansion is predictive of clinical deterioration, and increased morbidity and mortality

Plain Cranial Computed Tomography (CT) Scan & Contrast-Enhanced Computed Tomography (CT) Scan

  • CT scan differentiates ischemic stroke from intracerebral hemorrhage (ICH)
    • Scan will also show size, location and volume of hemorrhage
    • Intracerebral hemorrhage volume >30 mL has exponential risk with mortality
    • May reveal structural abnormalities (eg aneurysms, brain tumors) which may have caused intracerebral hemorrhage, or structural complications (eg herniation, hydrocephalus, intraventricular hemorrhage)
    • Contrast-enhanced CT scan is useful in identifying patients at high risk of hematoma expansion

Cranial Magnetic Resonance Imaging (MRI)

  • Equivalent to CT scan in determining the presence, size, location, and progression of acute intracerebral hemorrhage
  • Superior at detecting underlying structural lesions or tumor, delineating the amount of perihematomal edema and herniation and multiple old hemorrhages or microbleeds that suggest amyloid angiopathy
  • Used to check venous thrombosis, hemorrhages in high convexity, often bilateral and substantial edema

Angiography

  • CT angiography is useful in detecting hematoma expansion (spot sign)
  • Consider for all patients without clear cause of hemorrhage who are surgical candidates
    • Eg young, normotensive patients who are clinically stable
    • Useful in diagnosing secondary causes of intracerebral hemorrhage (eg aneurysm, arteriovenous malformation, venous sinus thrombosis, arteriovenous dural fistulae, vasculitis)
  • Angiography not required in older hypertensive patients who have hemorrhage in basal ganglia, cerebellum, thalamus, or brain stem and in whom CT does not show structural lesion
  •  Patient’s clinical state and neurologist/neurosurgeon’s discretion will determine the urgency and timing of angiography
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Less focus must be given on pretreatment blood pressure (BP) levels, which rarely predict future untreated BP levels or rule out capacity to benefit from BP lowering in high cardiovascular risk patients, according to recent study. Focus must be directed instead on prompt, empirical treatment to maintain lower BP for individuals with high BP or high risk.
16 Nov 2018
Atrial fibrillation appears to be the strongest determinant of stroke over 48 years of follow-up in males, a study has found.
15 Nov 2018
Psychological functioning consistently predicts symptom severity and health-related quality of life (hr-QOL) in atrial fibrillation (AF) patients with preserved left ventricular function, a recent study has found.
Audrey Abella, 16 Nov 2018
Supplementation with either omega-3 fatty acids (ie, fish oil) or vitamin D did not reduce the incidence of major cardiovascular (CV) events (ie, composite of myocardial infarction [MI], stroke, and CV death) or total invasive cancer, according to the VITAL* trial presented at AHA 2018.